Search Results - "Kroemer, M"

The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age by Orillard, E, Spehner, L, Mansi, L, Bouard, A, Falcoz, A, Lepiller, Q, Renaude, E, Pallandre, J R, Vienot, A, Kroemer, M, Borg, C

“…Cancer patients are at risk of severe COVID-19 infection, and vaccination is recommended. Nevertheless, we observe a failure of COVID-19 vaccines in this…”
Get full text

Which experimental models and explorations to use in regenerative endodontics? A comprehensive review on standard practices by Louvrier, A., Terranova, L., Meyer, C., Meyer, F., Euvrard, E., Kroemer, M., Rolin, G.

“…Since the discovery of dental pulp stem cells, a lot of teams have expressed an interest in dental pulp regeneration. Many approaches, experimental models and…”
Get full text

Influenza vaccination coverage at community pharmacies: Positioning, needs, expectations and involvement of community pharmacists in the Franche-Comté region by Kroemer, M., Clairet, A.L., Kabiche, K., Bendjama, A., Bertrand, X., Limat, S., Nerich, V.

“…•Influenza vaccination performed by community pharmacists was experimented over two consecutive winters (2017–2018 and 2018–2019) in 4 French pilot regions.•In…”
Get full text

New immunotherapeutic approaches in oncology and hematology by Kroemer, M, Turco, C, Galaine, J, Deschamps, M, Limat, S, Borg, C

“…Scientific advances in the last decade have demonstrated the critical role of host immune system in the elimination and suppression of cancer cells. Better…”
Get more information

Immunoadsorption Followed by Rituximab as a Definitive Treatment for Insulin Autoimmune Syndrome (Hirata Syndrome): A Case Report by Kroemer, Tim M, Erler, Anne, Tsourdi, Elena, Gruber, Matthias, Tselmin, Sergey, Julius, Ulrich, Aringer, Martin, Hofbauer, Lorenz C, Rachner, Tilman D

“…Insulin autoimmune syndrome (IAS) is a rare condition in which autoantibodies against insulin decrease degradation of insulin, resulting in fasting…”
Get full text

8P STC1, a baseline predictive biomarker for overall survival in metastatic colorectal cancer (mCRC) by Wespiser, M., Henriques, J., Kroemer, M., Mougey, V., Borg, C., Loyon, R., Jary, M.

Get full text

172P Phenotypic and functional heterogeneity of tissue resident memory T-cells in colorectal cancer liver metastasis by Abdeljaoued, S., Kroemer, M., Ben Khelil, M., Viot, J., Bouard, A., Monnien, F., Mougey, V., Loyon, R., Doussot, A., Heyd, B., Borg, C.

Get full text

1903PMyeloid derived suppressor cells but not regulatory T cells are associated with adaptive immunity and clinical outcomes in anal squamous cell carcinoma by Borg, C, Spehner, L, Kroemer, M, Kim, S, Jary, M, Vienot, A, Klajer, E, Ramseyer, M, Adotevi, O, Godet, Y, Andre, T, Buecher, B, Francois, E, Loyon, R

“…Abstract Background Anal squamous cell carcinoma (SCCA) is associated with E6 and E7 oncoproteins encoded by human papillomavirus (HPV) 16. Addition of…”
Get full text

Myeloid derived suppressor cells but not regulatory T cells are associated with adaptive immunity and clinical outcomes in anal squamous cell carcinoma by Borg, C., Spehner, L., Kroemer, M., Kim, S., Jary, M., Vienot, A., Klajer, E., Ramseyer, M., Adotevi, O., Godet, Y., Andre, T., Buecher, B., Francois, E., Loyon, R.

Get full text

1903P - Myeloid derived suppressor cells but not regulatory T cells are associated with adaptive immunity and clinical outcomes in anal squamous cell carcinoma by Borg, C., Spehner, L., Kroemer, M., Kim, S., Jary, M., Vienot, A., Klajer, E., Ramseyer, M., Adotevi, O., Godet, Y., Andre, T., Buecher, B., Francois, E., Loyon, R.

“…Anal squamous cell carcinoma (SCCA) is associated with E6 and E7 oncoproteins encoded by human papillomavirus (HPV) 16. Addition of Docetaxel to 5-Fluorouracil…”
Get full text

KS01.6.A UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM by Carpentier, A F, Verlut, C, Ghiringhelli, F, Bronnimann, C, Ursu, R, Fumet, J, Gherga, E, Lefort, F, Belin, C, Vernerey, D, Mathieu Larroquette, M, Hervieu, A, Laheurte, C, Meurisse, A, Jacquin, M, Malfroy, M, Kroemer, M, Clairet, A, Fagnoni-Legat, C, Lehmann-Che, J, Boullerot, L, Cuzzubbo, s, Adotevi, O

“…Abstract BACKGROUND The Telomerase Reverse Transcriptase (TERT) is activated in 85%-90% of cancers, and glioblastomas (GBM) harbor the highest incidence of…”
Get full text

Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus by Hommel, Ulrich, Erbel, Paul, Schiering, Nikolaus, D'Arcy, Allan, Renatus, Martin, Kroemer, Markus, Lim, Siew Pheng, Yin, Zheng, Keller, Thomas H, Vasudevan, Subhash G

“…The replication of flaviviruses requires the correct processing of their polyprotein by the viral NS3 protease (NS3pro). Essential for the activation of NS3pro…”
Get full text

1454P PARAFIRIGAST: Paclitaxel/ramucirumab versus FOLFIRI as second line chemotherapy of metastatic gastric cancer: An AGEO multicenter comparative study with a propensity score analysis by Wasselin, J., Vivier-Chicoteau, J., Pozet, A., Toullec, C., Racine Doat, S., Smolenschi, C., Turpin, A., De Rauglaudre, B., Sefrioui, D., Bouche, O., Zaanan, A., Kroemer, M., Pellat, A., Bignon Bretagne, A.L., Vitellius, C., Lavole, J., Goujon, G., Touchefeu, Y., Tougeron, D., Hautefeuille, V.

Get full text

4CPS-378 Oral therapy adherence and satisfaction in patients with multiple myeloma by Solano, M, Faure, C, Pain, C, Loriod, P, Maes, AC, Marguet, P, Kroemer, M, Rumpler, A, Daguindau, E, Limat, S, Clairet, AL

“…Background and importanceThe transition to oral therapies in patients with multiple myeloma (MM) offers potential benefits to patients, however they must…”
Get full text

PROSPECT OF STUDYING HARD X- AND GAMMA-RAYS FROM TYPE Ia SUPERNOVAE by MAEDA, K, TERADA, Y, TAMAGAWA, T, HILLEBRANDT, W, KASEN, D, RÖPKE, F. K, BAMBA, A, DIEHL, R, NOMOTO, K, KROMER, M, SEITENZAHL, I. R, YAMAGUCHI, H

Get full text

Structure and Catalytic Mechanism of l-Rhamnulose-1-phosphate Aldolase by Kroemer, Markus, Merkel, Iris, Schulz, Georg E

“…The structure of l-rhamnulose-1-phosphate aldolase has been established at 1.35 Å resolution in a crystal form that was obtained by a surface mutation and has…”
Get full text

Nouvelles approches d’immunothérapie en onco-hématologie by Kroemer, M., Turco, C., Galaine, J., Deschamps, M., Limat, S., Borg, C.

“…Les progrès scientifiques de cette dernière décennie ont permis de démontrer le rôle important du système immunitaire de l’hôte dans la lutte contre les…”
Get full text

The structure of l-rhamnulose-1-phosphate aldolase (class II) solved by low-resolution SIR phasing and 20-fold NCS averaging by Kroemer, Markus, Schulz, Georg E.

“…The enzyme l‐rhamnulose‐1‐phosphate aldolase catalyzes the reversible cleavage of l‐rhamnulose‐1‐phosphate to dihydroxyacetone phosphate and l‐­lactaldehyde…”
Get full text

Three structural snapshots of the FPPS catalytic cycle revealed by X-ray analyses of the human enzyme by Rondeau, J.-M., Bitsch, F., Bourgier, E., Geiser, M., Hemmig, R., Kroemer, M., Lehmann, S., Ramage, P., Rieffel, S., Strauss, A., Green ⁎, J.R., Jahnke, W.

Get full text

X-ray and 2D NMR analyses of the binding of nitrogen-containing bisphosphonate drugs to human FPPS by Rondeau, J.-M., Bitsch, F., Bourgier, E., Geiser, M., Hemmig, R., Kroemer, M., Lehmann, S., Ramage, P., Rieffel, S., Strauss, A., Green ⁎, J.R., Jahnke, W.

Get full text